Concepedia
Statistics
Publications
35
Citations
2.7K
H-Index
24
Active since
2008
Affiliations
Pfizer (United States)(Current)
Icahn School of Medicine at Mount Sinai
Hospital Clínic de Barcelona
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
Gary Chan is an author at Pfizer (United States) specializing in medicine, pharmacology, and janus kinase inhibitor therapy.
Publications per year
2008–2025
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen et al. · JAMA Dermatology · 2020 · 388 citations · Full text
Medicine, Dermatology, Pharmacology +12
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julián Panés, William J. Sandborn, Stefan Schreiber et al. · Gut · 2017 · 361 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans
Martin E. Dowty, Jinyan Lin, Tim F. Ryder et al. · Drug Metabolism and Disposition · 2014 · 274 citations
Pharmacy, Pharmacokinetics, Pharmacology +12
Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
William J. Sandborn, Julián Panés, Geert D’Haens et al. · Clinical Gastroenterology and Hepatology · 2018 · 244 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +9
Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
Kevin Winthrop, Gil Melmed, Séverine Vermeire et al. · Inflammatory Bowel Diseases · 2018 · 209 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +16
1–5 of 35